ALEC(Alector, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $207.09M | $133.60M | $97.10M | $100.56M | $21.05M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$37.36M | −$137.83M | −$151.74M | −$145.00M | −$156.01M |
| 净利润 | −$36.33M | −$133.31M | −$130.39M | −$119.05M | −$142.93M |
| 经营现金流 | $298.55M | −$20.33M | −$184.16M | −$229.91M | −$184.03M |
| 自由现金流 | $295.30M | −$24.45M | −$186.54M | −$231.16M | −$184.07M |
| 摊薄每股收益 | $-0.45 | $-1.62 | $-1.56 | $-1.23 | $-1.39 |